Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 657100
                    [Title] => A non-chemo therapy for breast cancer patients
                    [Summary] => 
Collateral damage.
                    [DatePublished] => 2011-02-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1422176
                    [AuthorName] => Joy Angelica  Subido
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 336730
                    [Title] => Putting value to health the GSK way
                    [Summary] => Almost a quarter of century working in the pharmaceuticals industry has helped Daisy Cembrano appreciate the drastic changes taking place in the sector.
                    [DatePublished] => 2006-05-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business As Usual
                    [SectionUrl] => business-as-usual
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 282860
                    [Title] => Palace intrigue
                    [Summary] => With Malacañang under siege because of the Gloriagate tape, once again the palace snakes are slithering out of their nests. Serpents from the group of the "tree" – a GMA media strategy group headed by a former Estrada Cabinet Secretary who defected to GMA’s camp and operating out of the Byron hotel on EDSA – are hissing that someone from the "Firm" is preparing to turn over the Palace keys to VP Noli de Castro.
                    [DatePublished] => 2005-06-21 00:00:00
                    [ColumnID] => 135725
                    [Focus] => 0
                    [AuthorID] => 1730160
                    [AuthorName] => S.A. Maguire
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 281828
                    [Title] => Parallel imports may open floodgates for entry of fake drugs to RP, says GSK
                    [Summary] => The proliferation of counterfeit drugs in the country could be partly attributed to government’s parallel drug importation program, a top executive of an international pharmaceutical company said yesterday.


Amado T. Tadena, president and managing director of GlaxoSmithKline (GSK), said counterfeit drugs now comprise between 10 percent to 15 percent of all drugs being sold in the local market, posing a continuing problem to the $1-billion pharmaceutical industry.


                    [DatePublished] => 2005-06-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1805266
                    [AuthorName] => Marianne V. Go
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 239331
                    [Title] => Local drug firms urged to price products reasonably
                    [Summary] => Trade and Industry Secretary Cesar V. Purisima appealed yesterday to local drug companies to be reasonable in pricing their medicines.


"We appeal to drug companies to make their medicines more accessible to consumer by reasonably pricing them," Purisima said.


Purisima noted that drug prices have become very expensive and that "getting sick is becoming a luxurious expense."


He expressed the view  that "genuine healthcare service also means making medicines within reach of the poor."


                    [DatePublished] => 2004-02-17 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1805266
                    [AuthorName] => Marianne V. Go
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

        )

)

VALUE HEALTH

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 657100
                    [Title] => A non-chemo therapy for breast cancer patients
                    [Summary] => 
Collateral damage.
                    [DatePublished] => 2011-02-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1422176
                    [AuthorName] => Joy Angelica  Subido
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 336730
                    [Title] => Putting value to health the GSK way
                    [Summary] => Almost a quarter of century working in the pharmaceuticals industry has helped Daisy Cembrano appreciate the drastic changes taking place in the sector.
                    [DatePublished] => 2006-05-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business As Usual
                    [SectionUrl] => business-as-usual
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 282860
                    [Title] => Palace intrigue
                    [Summary] => With Malacañang under siege because of the Gloriagate tape, once again the palace snakes are slithering out of their nests. Serpents from the group of the "tree" – a GMA media strategy group headed by a former Estrada Cabinet Secretary who defected to GMA’s camp and operating out of the Byron hotel on EDSA – are hissing that someone from the "Firm" is preparing to turn over the Palace keys to VP Noli de Castro.
                    [DatePublished] => 2005-06-21 00:00:00
                    [ColumnID] => 135725
                    [Focus] => 0
                    [AuthorID] => 1730160
                    [AuthorName] => S.A. Maguire
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 281828
                    [Title] => Parallel imports may open floodgates for entry of fake drugs to RP, says GSK
                    [Summary] => The proliferation of counterfeit drugs in the country could be partly attributed to government’s parallel drug importation program, a top executive of an international pharmaceutical company said yesterday.


Amado T. Tadena, president and managing director of GlaxoSmithKline (GSK), said counterfeit drugs now comprise between 10 percent to 15 percent of all drugs being sold in the local market, posing a continuing problem to the $1-billion pharmaceutical industry.


                    [DatePublished] => 2005-06-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1805266
                    [AuthorName] => Marianne V. Go
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 239331
                    [Title] => Local drug firms urged to price products reasonably
                    [Summary] => Trade and Industry Secretary Cesar V. Purisima appealed yesterday to local drug companies to be reasonable in pricing their medicines.


"We appeal to drug companies to make their medicines more accessible to consumer by reasonably pricing them," Purisima said.


Purisima noted that drug prices have become very expensive and that "getting sick is becoming a luxurious expense."


He expressed the view  that "genuine healthcare service also means making medicines within reach of the poor."


                    [DatePublished] => 2004-02-17 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1805266
                    [AuthorName] => Marianne V. Go
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

        )

)

abtest

A non-chemo therapy for breast cancer patients

By Joy Angelica Subido | February 15, 2011 - 12:00am

Collateral damage.

Health And Family

Putting value to health the GSK way

May 15, 2006 - 12:00am

Almost a quarter of century working in the pharmaceuticals industry has helped Daisy Cembrano appreciate the drastic changes taking place in the sector.

Business As Usual

Palace intrigue

By S.A. Maguire | June 21, 2005 - 12:00am

With Malacañang under siege because of the Gloriagate tape, once again the palace snakes are slithering out of their nests. Serpents from the group of the "tree" – a GMA media strategy group...

Business

Parallel imports may open floodgates for entry of fake drugs to RP, says GSK

By Marianne V. Go | June 16, 2005 - 12:00am

The proliferation of counterfeit drugs in the country could be partly attributed to government’s parallel drug importation program, a top executive of an international pharmaceutical company said yesterday. Amado...

Business

Local drug firms urged to price products reasonably

By Marianne V. Go | February 17, 2004 - 12:00am

Trade and Industry Secretary Cesar V. Purisima appealed yesterday to local drug companies to be reasonable in pricing their medicines. "We appeal to drug companies to make their medicines more accessible to...

Business